Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.
Dxcover has raised $6.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Dxcover's investors include British Business Bank, University of Strathclyde, Scottish Enterprise, Maven Capital Partners, Innovate UK.
Dxcover is headquartered in Glasgow, United Kingdom.
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.
Dxcover is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dxcover — Funding & Investors." VCBacked, February 3, 2025, https://www.vcbacked.co/company/dxcover. Accessed July 19, 2026.
VCBacked. (2025). Dxcover — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/dxcover
{{cite web |title=Dxcover — Funding & Investors |url=https://www.vcbacked.co/company/dxcover |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated